课题基金 / 基金详情

Characterisation and regulation of the alternative cap binding complex consisting of NCBP1 and -3

Characterisation and regulation of the alternative cap binding complex consisting of NCBP1 and -3
由 NCBP1 和 -3 组成的替代帽结合复合物的表征和调控
批准号:
319884736
负责人:
Professor Dr. Andreas Pichlmair
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31

项目摘要

项目成果

Professor Dr. Andreas Pichlmair的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The flow of genomic information from DNA to protein requires polymerase-II transcripts, which are characterized by the presence of a 5 primes cap structure. The cap-binding complex (CBC), consisting of the nuclear cap binding protein (NCBP) 2 and its adaptor NCBP1, is believed to bind all capped RNA and to be necessary for processing and intracellular localization. However, NCBP1 but not NCBP2 is required for cell viability and mRNA export suggesting the existence of additional factors involved in mRNA biology. We recently identified an alternative cap-binding complex consisting of the highly conserved protein C17orf85 (now officially named NCBP3 for Nuclear cap-binding protein 3) and NCBP1. Only simultaneous depletion of NCBP2 and -3 diminishes association of NCBP1 to cap-RNA, impairs cell growth and nuclear mRNA export. mRNA binds either NCBP2 or -3 whereas small RNA species such as snRNA preferentially associates to NCBP2. Thus, besides the canonical CBC consisting of NCBP1/2, an alternative CBC consisting of NCBP1/3 is operating in most eukaryotic cells. It is currently unclear why our organism evolved two CBCs that under steady state conditions share large parts of their activity. Intriguingly, under cellular stress conditions such as virus infection NCBP3 becomes pivotal to regulate a proper antiviral immune response. This suggests that mRNA maturation and translocation may be differentially regulated depending on environmental stimuli. Here, we aim to functionally characterize the alternative CBC under steady state and stimulated conditions. Therefore, the interactions between NCBP1 and -3 as well as association of RNA processing factors to the NCBP1/3 complex should be studied in detail. A further aim is to study why mRNA but not other types of capped RNAs (e.g. snRNA, lincRNA,...) are associated with the alternative CBC. Functionally, the alternative CBC appears to be required during the antiviral immune response suggesting influence of innate pathogen sensing on the mRNA export pathway. In preliminary experiments we could identify unique phosphorylation sites on NCBP1 and -3 that are dynamically changing during virus infection. The function of these phosphorylation sites will be evaluated in the context of the antiviral immune response. A recently developed NCBP3 deficient mouse will be of critical help to gain functional insights on an organismal level. In sum this proposal aims to gain further insights in a fundamental cellular process, namely the regulation of information transfer from DNA to protein. Preliminary data let us hypothesize that this process is controlled through integrating signals elicited by environmental stimuli.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a novel nucleotide based second messenger system regulating innate immune responses
  • 批准号:
    423400107
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Professor Dr. Andreas Pichlmair
  • 依托单位:
Calpain 15 activity in immune regulation
  • 批准号:
    406318528
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    Professor Dr. Andreas Pichlmair
  • 依托单位:
The role of cellular triphosphorylated-RNA interacting proteins in antiviral immunity
  • 批准号:
    232151274
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Professor Dr. Andreas Pichlmair
  • 依托单位:
Viral Disease Mapping Initiative
  • 批准号:
    458896032
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professor Dr. Andreas Pichlmair
  • 依托单位:
国内基金
海外基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
  • 批准号:
    82371770
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    宁铂涛
  • 依托单位: